Location History:
- Taipei, TW (2014)
- Nantou County, TW (2015)
Company Filing History:
Years Active: 2014-2015
Title: Innovations of Tsung-Chih Chen
Introduction
Tsung-Chih Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for cancer treatment. With a total of three patents to his name, his work showcases a commitment to advancing medical science.
Latest Patents
One of Tsung-Chih Chen's latest patents involves a series of novel thiochromeno[2,3-c]quinolin-12-one derivatives. This invention provides a preparation method and application for these derivatives, which are designed to inhibit topoisomerase types I and II, thereby effectively treating cancer cell growth. Another significant patent focuses on heterocyclic fused anthraquinone derivatives, detailing a manufacturing method and pharmaceutical composition that utilizes these compounds. The derivatives are represented by a specific formula, with various substituents that enhance their therapeutic potential.
Career Highlights
Tsung-Chih Chen is affiliated with the National Defense Medical Center, where he applies his expertise in medicinal chemistry. His work is instrumental in developing innovative solutions for complex medical challenges, particularly in oncology.
Collaborations
Throughout his career, Tsung-Chih Chen has collaborated with esteemed colleagues, including Hsu-Shan Huang and Dah-Shyong Yu. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Tsung-Chih Chen's contributions to the field of pharmaceuticals through his innovative patents reflect his dedication to improving cancer treatment. His work continues to inspire advancements in medical research and development.